Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SEER

Seer (SEER)

Seer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SEER
DateTimeSourceHeadlineSymbolCompany
23/08/202406:05GlobeNewswire Inc.Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:SEERSeer Inc
17/08/202406:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
15/08/202406:05GlobeNewswire Inc.Seer Appoints Nicolas Roelofs to its Board of DirectorsNASDAQ:SEERSeer Inc
09/08/202421:00GlobeNewswire Inc.Seer to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:SEERSeer Inc
09/08/202406:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEERSeer Inc
09/08/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
09/08/202406:05GlobeNewswire Inc.Seer Reports Second Quarter 2024 Financial ResultsNASDAQ:SEERSeer Inc
03/08/202408:33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SEERSeer Inc
20/07/202406:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
19/07/202406:03GlobeNewswire Inc.Seer to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:SEERSeer Inc
13/07/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
15/06/202406:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
15/06/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEERSeer Inc
12/06/202401:11GlobeNewswire Inc.Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker DiscoveryNASDAQ:SEERSeer Inc
03/06/202400:55GlobeNewswire Inc.Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection StudyNASDAQ:SEERSeer Inc
09/05/202406:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEERSeer Inc
09/05/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
09/05/202406:05GlobeNewswire Inc.Seer Reports First Quarter 2024 Financial ResultsNASDAQ:SEERSeer Inc
09/05/202406:03GlobeNewswire Inc.Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic SolutionsNASDAQ:SEERSeer Inc
24/04/202406:05GlobeNewswire Inc.Seer to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:SEERSeer Inc
07/03/202408:14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SEERSeer Inc
01/03/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
01/03/202408:05GlobeNewswire Inc.Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 OutlookNASDAQ:SEERSeer Inc
24/02/202409:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEERSeer Inc
22/02/202408:05GlobeNewswire Inc.Seer to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:SEERSeer Inc
08/02/202413:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEERSeer Inc
07/02/202400:00GlobeNewswire Inc.Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker DiscoveryNASDAQ:SEERSeer Inc
02/02/202408:05GlobeNewswire Inc.Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024NASDAQ:SEERSeer Inc
04/01/202400:52Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SEERSeer Inc
23/12/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
 Showing the most relevant articles for your search:NASDAQ:SEER